Pharma
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
The chief information officer explains how digital transformation's rapid pace is changing the role and helping him work with C-suite leaders to create healthcare strategy.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.
The company announced a $200 million Series C round in January.
The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials.
HIMSS22
First Databank president Bob Katter discusses the FDB Vela electronic prescribing network and how it will give patients with more control over their prescriptions.
HIMSS22
Joining with like-minded healthcare and technology pros can help develop skills in leadership to overcome new challenges, says Amy Chacko, past president of HIMSS New England Chapter.
HIMSS22
Precision medicine is entering the mainstream, from genetic insights informing a range of specialties to primary care using pharmacogenomics, according to Dr. Joel Diamond of 2bPrecise.
The partnership will allow Withings' connected scales, blood pressure monitors and sleep-tracking mats to integrate with Medable's trial platform.